EUCAFILIPT®

Ukraine

The drug is used for inflammatory diseases of the throat, nasopharynx, and oral cavity (e.g., tracheitis, laryngitis, pharyngitis, stomatitis), for skin injuries (including infected wounds), as well as for mild forms of neurotic disorders, such as irritability, emotional instability, or sleep disturbances.

Brand name EUCAFILIPT®
Dosage form tincture
Active substance / Dosage
eucalyptus leaves · not less than 0.2 mg cineole per 1 ml
Prescription type over-the-counter (OTC)
ATC code
Registration number UA/15852/01/01
EUCAFILIPT® tincture

Frequently asked questions

How should Eucafilipt® be taken correctly?

Adults should take 15-30 drops (1 teaspoon) orally, diluted in a quarter glass of boiled water, 3-4 times a day after meals. For children aged 12 and older: 1 drop per year of age, 3-4 times a day after meals. The tincture can also be used for mouth rinsing (10-15 drops per 200 ml of water) or for steam inhalations.

What are the possible side effects of Eucafilipt®?

Nausea, vomiting, and diarrhea are possible. Allergic reactions may also occur: urticaria, redness, rash, itching, Quincke's edema, or contact dermatitis in the lip area. In case of severe reactions, use should be discontinued.

Who should not use this drug?

Contraindications include bronchial asthma, bronchospasm, gastrointestinal and biliary tract diseases, severe liver diseases, as well as individual hypersensitivity to the components of the product.

Can the drug be taken by pregnant women or children?

Due to the ethyl alcohol content, oral administration of the tincture is not recommended for pregnant and breastfeeding women. Oral administration is also not recommended for children under 12 years of age.

Does the drug affect the ability to drive a vehicle?

Yes, when taking the tincture orally, one should refrain from driving vehicles and operating potentially dangerous machinery.

Instructions for use

INSTRUCTION for medical use of the medicinal product EUCAPHYLIPT® (EUCAPHYLIPT)

Composition:

Active substance: Eucalyptus leaf tincture (1:10) (extractant – 96% ethanol); 1 ml of the preparation contains 1 ml of Eucalyptus leaf tincture (1:10) (extractant – 96% ethanol), calculated as cineole – not less than 0.2 mg;

Excipient: zinc chloride.

Pharmaceutical form. Tincture.

Main physicochemical properties: liquid, ranging in color from green to dark green. Sediment formation may occur during storage.

Pharmacotherapeutic group. Medicinal products used in throat diseases. Antiseptics. ATC code R02AA20.

Pharmacological properties.

The tincture contains tannins, ellagic acid, flavonoids, resins, wax, and essential oil, which includes various terpenoid compounds particularly active against gram-positive and gram-negative microorganisms, exerting a detrimental effect on fungi and protozoa. Eucalyptus suppresses the growth of Staphylococcus aureus, Escherichia coli, Mycobacterium tuberculosis, Trichomonas, and Entamoeba histolytica. The main component of the essential oil is cineole, a monocyclic terpene. The tincture exerts antiseptic, anti-inflammatory, and disinfectant actions, which are due to the oxidative effect of the monocyclic terpene cineole and anti-inflammatory influence associated with virtually all physiologically active substances contained in its composition. The medicinal product also has a moderate sedative (calming) effect.

The preparation demonstrates antibacterial activity against staphylococci.

Clinical characteristics.

Indications.

Inflammatory diseases of the upper respiratory tract, nasopharynx, and oral cavity (tracheitis, laryngitis, pharyngitis, gingivitis, stomatitis), skin injuries (including infected wounds), as well as mild forms of neurotic disorders (irritability, emotional lability, difficulty falling asleep and sleep disturbances).

Contraindications.

Bronchial asthma, bronchospasm. Inflammatory diseases of the gastrointestinal tract and biliary passages. Severe liver disease. Individual hypersensitivity to the drug.

Interaction with other medicinal products and other forms of interactions.

Not established.

Special precautions for use.

The medicinal product contains ethanol in an amount of not less than 88.0% (v/v).

Use during pregnancy or breastfeeding.

Since ethanol is an ingredient of the tincture, it is not recommended for oral use in women during pregnancy or breastfeeding.

Ability to affect reaction rate when driving or operating machinery.

When taking the tincture orally, avoid driving vehicles or operating potentially hazardous machinery.

Dosage and Administration.

The tincture is taken orally and can also be used for rinsing and steam inhalations.

Shake well before use.

Adults are recommended to take 15–30 drops of the tincture (1 teaspoon) orally, previously diluted in ¼ cup of boiled water, 3–4 times daily after meals. For children aged 12 years and older, the dosage is calculated as 1 drop per year of life, 3–4 times daily after meals.

For rinsing, dilute 10–15 drops of the tincture in 200 ml of warm boiled water.

For steam inhalations, use the tincture undiluted or diluted with water (as for rinsing) with inhalers of any type.

The duration of treatment depends on the therapeutic effect achieved, as determined by the physician.

Children.

Since ethanol is an ingredient of the tincture, oral administration is not recommended for children under 12 years of age.

Overdose.

Not established.

Adverse reactions.

Nausea, vomiting, and diarrhea. In case of hypersensitivity to the drug, allergic reactions may occur (urticaria, skin redness and rashes, itching, Quincke's edema); sometimes contact dermatitis (in the lip area). If pronounced reactions occur, the drug should be discontinued.

Shelf life. 2 years.

Storage conditions.

Store in a place inaccessible to children.

Store in the original packaging at a temperature not exceeding 25 °C.

Sedimentation may occur during storage.

Do not use after the expiry date.

Packaging.

100 ml in bottles No. 1 in a pack.

100 ml in jars No. 1 in a pack.

Dispensing category. Over-the-counter.

Manufacturer.

PJSC "CHIMFARMPRODUCT 'CHERVONA ZIRKA'".

Manufacturer's location and address of business activity.

Ukraine, 61010, Kharkiv region, city of Kharkiv, Gordeyenkivska Street, building 1.

Similar drugs

The original data is available in the language of the country of manufacture.

Data source: State Register of Medicinal Products of Ukraine

Data last verified: August 13, 2026